Report Detail

Pharma & Healthcare Global and Japan NSAIDs Market Insights, Forecast to 2026

  • RnM4194867
  • |
  • 08 September, 2020
  • |
  • Global
  • |
  • 144 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

NSAIDs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global NSAIDs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the NSAIDs market is segmented into
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others

Segment by Application, the NSAIDs market is segmented into
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment

Regional and Country-level Analysis
The NSAIDs market is analysed and market size information is provided by regions (countries).
The key regions covered in the NSAIDs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and NSAIDs Market Share Analysis
NSAIDs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NSAIDs business, the date to enter into the NSAIDs market, NSAIDs product introduction, recent developments, etc.
The major vendors covered:
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell


1 Study Coverage

  • 1.1 NSAIDs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key NSAIDs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global NSAIDs Market Size Growth Rate by Type
    • 1.4.2 Aspirin
    • 1.4.3 Ibuprofen
    • 1.4.4 Naproxen
    • 1.4.5 Nabumetone
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global NSAIDs Market Size Growth Rate by Application
    • 1.5.2 Back Pain Treatment
    • 1.5.3 Osteoarthritis Treatment
    • 1.5.4 Other Disease Treatment
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global NSAIDs Market Size, Estimates and Forecasts
    • 2.1.1 Global NSAIDs Revenue 2015-2026
    • 2.1.2 Global NSAIDs Sales 2015-2026
  • 2.2 Global NSAIDs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 NSAIDs Historical Market Size by Region (2015-2020)
    • 2.3.1 Global NSAIDs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global NSAIDs Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 NSAIDs Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global NSAIDs Sales Forecast by Region (2021-2026)
    • 2.4.2 Global NSAIDs Revenue Forecast by Region (2021-2026)

3 Global NSAIDs Competitor Landscape by Players

  • 3.1 Global Top NSAIDs Sales by Manufacturers
    • 3.1.1 Global NSAIDs Sales by Manufacturers (2015-2020)
    • 3.1.2 Global NSAIDs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global NSAIDs Manufacturers by Revenue
    • 3.2.1 Global NSAIDs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global NSAIDs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global NSAIDs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by NSAIDs Revenue in 2019
    • 3.2.5 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global NSAIDs Price by Manufacturers
  • 3.4 Global NSAIDs Manufacturing Base Distribution, Product Types
    • 3.4.1 NSAIDs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers NSAIDs Product Type
    • 3.4.3 Date of International Manufacturers Enter into NSAIDs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global NSAIDs Market Size by Type (2015-2020)
    • 4.1.1 Global NSAIDs Sales by Type (2015-2020)
    • 4.1.2 Global NSAIDs Revenue by Type (2015-2020)
    • 4.1.3 NSAIDs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global NSAIDs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global NSAIDs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global NSAIDs Revenue Forecast by Type (2021-2026)
    • 4.2.3 NSAIDs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global NSAIDs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global NSAIDs Market Size by Application (2015-2020)
    • 5.1.1 Global NSAIDs Sales by Application (2015-2020)
    • 5.1.2 Global NSAIDs Revenue by Application (2015-2020)
    • 5.1.3 NSAIDs Price by Application (2015-2020)
  • 5.2 NSAIDs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global NSAIDs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global NSAIDs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global NSAIDs Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan NSAIDs Market Size YoY Growth 2015-2026
    • 6.1.1 Japan NSAIDs Sales YoY Growth 2015-2026
    • 6.1.2 Japan NSAIDs Revenue YoY Growth 2015-2026
    • 6.1.3 Japan NSAIDs Market Share in Global Market 2015-2026
  • 6.2 Japan NSAIDs Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top NSAIDs Players by Sales (2015-2020)
    • 6.2.2 Japan Top NSAIDs Players by Revenue (2015-2020)
  • 6.3 Japan NSAIDs Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan NSAIDs Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan NSAIDs Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan NSAIDs Price by Type (2015-2020)
  • 6.4 Japan NSAIDs Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan NSAIDs Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan NSAIDs Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan NSAIDs Price Forecast by Type (2021-2026)
  • 6.5 Japan NSAIDs Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan NSAIDs Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan NSAIDs Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan NSAIDs Price by Application (2015-2020)
  • 6.6 Japan NSAIDs Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan NSAIDs Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan NSAIDs Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan NSAIDs Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America NSAIDs Market Size YoY Growth 2015-2026
  • 7.2 North America NSAIDs Market Facts & Figures by Country
    • 7.2.1 North America NSAIDs Sales by Country (2015-2020)
    • 7.2.2 North America NSAIDs Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe NSAIDs Market Size YoY Growth 2015-2026
  • 8.2 Europe NSAIDs Market Facts & Figures by Country
    • 8.2.1 Europe NSAIDs Sales by Country
    • 8.2.2 Europe NSAIDs Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific NSAIDs Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific NSAIDs Market Facts & Figures by Country
    • 9.2.1 Asia Pacific NSAIDs Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific NSAIDs Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America NSAIDs Market Size YoY Growth 2015-2026
  • 10.2 Latin America NSAIDs Market Facts & Figures by Country
    • 10.2.1 Latin America NSAIDs Sales by Country
    • 10.2.2 Latin America NSAIDs Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa NSAIDs Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa NSAIDs Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa NSAIDs Sales by Country
    • 11.2.2 Middle East and Africa NSAIDs Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Bayer
    • 12.1.1 Bayer Corporation Information
    • 12.1.2 Bayer Description and Business Overview
    • 12.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Bayer NSAIDs Products Offered
    • 12.1.5 Bayer Recent Development
  • 12.2 Novacap
    • 12.2.1 Novacap Corporation Information
    • 12.2.2 Novacap Description and Business Overview
    • 12.2.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Novacap NSAIDs Products Offered
    • 12.2.5 Novacap Recent Development
  • 12.3 Abbott
    • 12.3.1 Abbott Corporation Information
    • 12.3.2 Abbott Description and Business Overview
    • 12.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Abbott NSAIDs Products Offered
    • 12.3.5 Abbott Recent Development
  • 12.4 Pfizer
    • 12.4.1 Pfizer Corporation Information
    • 12.4.2 Pfizer Description and Business Overview
    • 12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Pfizer NSAIDs Products Offered
    • 12.4.5 Pfizer Recent Development
  • 12.5 Johnson & Johnson
    • 12.5.1 Johnson & Johnson Corporation Information
    • 12.5.2 Johnson & Johnson Description and Business Overview
    • 12.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Johnson & Johnson NSAIDs Products Offered
    • 12.5.5 Johnson & Johnson Recent Development
  • 12.6 Cigna
    • 12.6.1 Cigna Corporation Information
    • 12.6.2 Cigna Description and Business Overview
    • 12.6.3 Cigna Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Cigna NSAIDs Products Offered
    • 12.6.5 Cigna Recent Development
  • 12.7 Geri-Care Pharmaceuticals
    • 12.7.1 Geri-Care Pharmaceuticals Corporation Information
    • 12.7.2 Geri-Care Pharmaceuticals Description and Business Overview
    • 12.7.3 Geri-Care Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
    • 12.7.5 Geri-Care Pharmaceuticals Recent Development
  • 12.8 Perrigo Company
    • 12.8.1 Perrigo Company Corporation Information
    • 12.8.2 Perrigo Company Description and Business Overview
    • 12.8.3 Perrigo Company Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Perrigo Company NSAIDs Products Offered
    • 12.8.5 Perrigo Company Recent Development
  • 12.9 Kopran
    • 12.9.1 Kopran Corporation Information
    • 12.9.2 Kopran Description and Business Overview
    • 12.9.3 Kopran Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Kopran NSAIDs Products Offered
    • 12.9.5 Kopran Recent Development
  • 12.10 Merck Sharp & Dohme
    • 12.10.1 Merck Sharp & Dohme Corporation Information
    • 12.10.2 Merck Sharp & Dohme Description and Business Overview
    • 12.10.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Merck Sharp & Dohme NSAIDs Products Offered
    • 12.10.5 Merck Sharp & Dohme Recent Development
  • 12.11 Bayer
    • 12.11.1 Bayer Corporation Information
    • 12.11.2 Bayer Description and Business Overview
    • 12.11.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Bayer NSAIDs Products Offered
    • 12.11.5 Bayer Recent Development
  • 12.12 GlaxoSmithKline
    • 12.12.1 GlaxoSmithKline Corporation Information
    • 12.12.2 GlaxoSmithKline Description and Business Overview
    • 12.12.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 GlaxoSmithKline Products Offered
    • 12.12.5 GlaxoSmithKline Recent Development
  • 12.13 Reddy Pharmaceuticals
    • 12.13.1 Reddy Pharmaceuticals Corporation Information
    • 12.13.2 Reddy Pharmaceuticals Description and Business Overview
    • 12.13.3 Reddy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 12.13.4 Reddy Pharmaceuticals Products Offered
    • 12.13.5 Reddy Pharmaceuticals Recent Development
  • 12.14 Verywell
    • 12.14.1 Verywell Corporation Information
    • 12.14.2 Verywell Description and Business Overview
    • 12.14.3 Verywell Sales, Revenue and Gross Margin (2015-2020)
    • 12.14.4 Verywell Products Offered
    • 12.14.5 Verywell Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key NSAIDs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 NSAIDs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on NSAIDs. Industry analysis & Market Report on NSAIDs is a syndicated market report, published as Global and Japan NSAIDs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of NSAIDs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,120.00
    4,680.00
    6,240.00
    3,630.90
    5,446.35
    7,261.80
    606,099.00
    909,148.50
    1,212,198.00
    325,650.00
    488,475.00
    651,300.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report